Maria Danila, MD, MSc
Enriched profileProfessor of Medicine · University of Alabama at Birmingham (UAB)
Maria Danila is Professor of Medicine at University of Alabama at Birmingham (UAB). OpenAlex indexes 157 publications with 4,779 citations (h-index 32); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 2 Sept 2026
Maria I. Danila is Professor of Medicine at University of Alabama at Birmingham (UAB), Division of Clinical Immunology and Rheumatology, Heersink School of Medicine. The public record shows 157 publications with 4,779 citations (h-index 32), centered on Rheumatoid Arthritis. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 5 companies, 2 NIH-funded awards (2012–2026).
- Most recent indexed publication: 2026 · Journal of clinical rheumatology
- Top research focus: Rheumatoid Arthritis
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 2 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 29 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 2 Sept 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Testimonials and Navigation in Rheumatology
Sponsor: University of Alabama at Birmingham
- RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
Sponsor: University of Alabama at Birmingham
- Comparing Modes of Telehealth Delivery: Phone vs. Video Visits (ASSIST)
Sponsor: University of Alabama at Birmingham
Industry payments
Updated 2 Sept 2026
5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20253 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202412 payments
- GENZYME CORPORATIONProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
49.2%Folate Analog Metabolic Inhibitor19.8%Methotrexate100%Part D≥24 patientsTNF inhibitor17.1%Humira(Cf) Pen41%Enbrel Sureclick37%Humira Pen22%Part D<11 patientsAntiparasitic
20.2%Antimalarial20.2%Hydroxychloroquine Sulfate100%Part D≥31 patientsMetabolism & gastrointestinal
12.2%Corticosteroid12.2%Prednisone100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 2 Sept 2026
2 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases
University of Alabama at Birmingham
FY2026$1,230,473R01MD019235 - Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases
University of Alabama at Birmingham
FY2025$614,732R01MD019235 - Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases
University of Alabama at Birmingham
FY2024$603,165R01MD019235
Publications
Updated 2 Sept 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Developing and Piloting a Standardized Thermography Protocol to Expedite Rheumatology Referrals for Possible Inflammatory Arthritis.
Journal of clinical rheumatology
Article2026 - Challenges to Research Integrity in Rheumatology: The Threat of Paper Mills, Fraud, and Click Data Science.
Arthritis & rheumatology (Hoboken, N.J.)
Article2026 - Outpatient Gout Follow-up After an Emergency Department Visit for Gout Flares.
Journal of clinical rheumatology
Article2025 - Profile of Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Single-Center Study.
European journal of rheumatology
Article2025
Online presence
Updated 2 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/maria-danila-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Maria-Danila
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/maio-danila
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
rheumnow.com/user/27419
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumnow.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 2 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- MSc
MSPH (advanced degrees, institution not specified in public sources)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumnow.com ↗ - Board Certified
Rheumatology (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumnow.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumnow.com ↗
- Associate Editor
Arthritis Care & Research (ACR journal)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumnow.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Secondary affiliations
appointments beyond the home institution- Physician Scientist
Geriatric Research Education and Clinical Center (GRECC), Birmingham VA Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumnow.com ↗ - Associate Division Director for Clinical Research
Division of Clinical Immunology and Rheumatology, UAB
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumnow.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheumnow.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Jeffrey Curtis, MD
University of Alabama at Birmingham (UAB)
Orlando Gutierrez, MD
University of Alabama at Birmingham (UAB)
Pankaj Arora, MD
University of Alabama at Birmingham (UAB)